In the group of patients with CKD, it was confirmed that low plasma concentrations of TRAIL are also an indicator of the progression of atherosclerotic lesions, as has been demonstrated in the carotid and femoral arteries [79]. This evidence concerns the gene TNFSF10 and chronic kidney disease.